PatientsLikeMe, a Cambridge, MA-based provider of a social networking website for patients, reports today that the Swiss drug giant Novartis is supporting the startup’s development of a new online community for people who have received organ transplants. No financial details about the startup’s deal with Novartis were revealed. Novartis, which has a large R&D organization in Cambridge, has worked with PatientsLikeMe in the past to learn about patients with multiple sclerosis, for which PatientsLikeMe has an online community. (Xconomy covered PatientsLikeMe’s strategy for working with pharma customers like Novartis last month.)
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
